Cardiovascular risk factors associated with insulin resistance: effects of oral antidiabetic agents.

Cardiovascular risk factors associated with insulin resistance: effects of oral antidiabetic agents.

Item
http://www.wikidata.org/entity/Q36131338
Pioglitazone, but not metformin, reduces liver fat in Type-2 diabetes mellitus independent of weight changes.Therapies for type 2 diabetes: lowering HbA1c and associated cardiovascular risk factorsPioglitazone and metformin fixed-dose combination in type 2 diabetes mellitus: an evidence-based review of its place in therapyPioglitazone: an antidiabetic drug with the potency to reduce cardiovascular mortality.Pioglitazone: an antidiabetic drug with cardiovascular therapeutic effects.Metformin: an old but still the best treatment for type 2 diabetes.Pioglitazone: update on an oral antidiabetic drug with antiatherosclerotic effects.Cardioprotective role of insulin: Advantage analogues.Animal models of catheter-induced intimal hyperplasia in type 1 and type 2 diabetes and the effects of pharmacologic intervention.Cardiovascular risks and benefits with oral drugs for Type 2 diabetes mellitus.Pleiotropic action of short-term metformin and fenofibrate treatment, combined with lifestyle intervention, in type 2 diabetic patients with mixed dyslipidemia.Comparison of metformin, gliclazide MR and rosiglitazone in monotherapy and in combination for type 2 diabetes.Population exposure-response modeling of metformin in patients with type 2 diabetes mellitus.A Peroxisome-Inspired Chemiluminescent Silica Nanodevice for the Intracellular Detection of Biomarkers and Its Application to Insulin-Sensitizer Screening.
P2860

Cardiovascular risk factors associated with insulin resistance: effects of oral antidiabetic agents.

Item
http://www.wikidata.org/entity/Q36131338
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Cardiovascular risk factors as ...... s of oral antidiabetic agents.
@ast
Cardiovascular risk factors as ...... s of oral antidiabetic agents.
@en
type
label
Cardiovascular risk factors as ...... s of oral antidiabetic agents.
@ast
Cardiovascular risk factors as ...... s of oral antidiabetic agents.
@en
prefLabel
Cardiovascular risk factors as ...... s of oral antidiabetic agents.
@ast
Cardiovascular risk factors as ...... s of oral antidiabetic agents.
@en
P1433
P1476
P2093
P2888
P304
P31
P356
P433
P478
P577
P6179
P698
P921
P356
P1433
P1476
Cardiovascular risk factors as ...... s of oral antidiabetic agents.
@en
P2093
P2888
P304
P31
P356
10.2165/00129784-200505030-00006
P433
P478
P577
P6179
P698
P921